BELLEVUE LIFE SCIENCES ACQUISITION CORP.
None
None, None [HQ]
Cash Flow Statements
4 Records · Starting from 2020In Million USD. Margins, Growth Rates In %
| Metric | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Operating Cash Flow (OCF) | - - | - - | - - | - - | |
| Operating Cash (Net) | - - | - - | - - | - - | |
| Accounts Receivable | - - | - - | - - | - - | |
| Accounts Payable | - - | - - | - - | 1.00 | |
|
Working Capital
|
- - | - - | - - | - - | |
| Change | - - | - - | - - | 1.00 | |
| Other WC | - - | - - | - - | 1.00 | |
| Investing Activities | |||||
| Used Cash (Net) | - - | - - | - - | -33.00 | |
| Capital Expenditure | - - | - - | - - | - - | |
| Purchases of Investments | - - | - - | - - | -70.00 | |
| Sale/Maturity of Investment | - - | - - | - - | 36.00 | |
| Property, Plant, Equipment (P&PE) | - - | - - | - - | - - | |
| Acquisitions (Net) | - - | - - | - - | - - | |
| Other Investing Activities | - - | - - | - - | -33.00 | |
| Financing Activities | |||||
| Used Cash (Net) | - - | - - | - - | -34.00 | |
| Debt Repayment | - - | - - | - - | -1.00 | |
| Dividends Paid | - - | - - | - - | - - | |
|
Common Stock
|
- - | - - | - - | 107 | |
| Issued | - - | - - | - - | 71.00 | |
| Repurchased | - - | - - | - - | -35.00 | |
| Other Financing Activities | - - | - - | 1.00 | -1.00 | |
| Cash Balances | |||||
| Begin of Period | - - | - - | - - | - - | |
| End of Period | - - | - - | - - | - - | |
| Change | - - | - - | - - | - - | |
| Non-Cash Balances | |||||
| Depreciation and Amortization | - - | - - | - - | - - | |
| Stock Based Compensation | - - | - - | - - | - - | |
| Other | - - | - - | - - | -2.00 | |
| Highlighted metrics | |||||
| Free Cash Flow (FCF) | - - | - - | - - | - - | |
| Cash Conversion Cycle (CCC) | - - | - - | - - | - - | |
| Invested Capital | - - | - - | - - | - - | |
|
Other Operating Inflows/Outflows
|
|||||
| Forex Effect on Cash | - - | - - | - - | - - |